We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+63.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.14B
AUM Growth
-$64.4M
Cap. Flow
-$67M
Cap. Flow %
-5.9%
Top 10 Hldgs %
37.98%
Holding
98
New
9
Increased
18
Reduced
57
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$14.8M
2
GM icon
General Motors
GM
+$4.52M
3
HES
Hess
HES
+$3.93M
4
BA icon
Boeing
BA
+$3.34M
5
UAL icon
United Airlines
UAL
+$3.03M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$10.3M
2
CMCSA icon
Comcast
CMCSA
+$9.19M
3
T icon
AT&T
T
+$7.11M
4
KR icon
Kroger
KR
+$5.44M
5
ESRX
Express Scripts Holding Company
ESRX
+$5.08M

Sector Composition

Rank Sector Weight
1 Healthcare 19.16%
2 Financials 15.68%
3 Technology 14.82%
4 Communication Services 11.33%
5 Industrials 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.22T
$49.7M 4.37%
1,845,360
-121,124
-6% -$3.24M
AAPL icon
2
Apple
AAPL
$4.81T
$45.8M 4.03%
1,459,400
-152,020
-9% -$4.86M
ESRX
3
DELISTED
Express Scripts Holding Company
ESRX
$45.7M 4.03%
513,800
-58,199
-10% -$5.08M
CMCSA icon
4
Comcast
CMCSA
$85.1B
$45M 3.97%
1,497,838
-313,200
-17% -$9.19M
GE icon
5
GE Aerospace
GE
$353B
$43.7M 3.85%
343,428
+9,747
+3% +$1.26M
VTRS icon
6
Viatris
VTRS
$20.5B
$42.5M 3.75%
626,718
-145,250
-19% -$10.3M
GM icon
7
General Motors
GM
$71.7B
$42.1M 3.71%
1,264,600
+126,600
+11% +$4.52M
IRM icon
8
Iron Mountain
IRM
$37.4B
$40.4M 3.56%
1,304,800
-18,200
-1% -$637K
COF icon
9
Capital One
COF
$127B
$39.1M 3.44%
444,000
+19,500
+5% +$1.64M
USB icon
10
US Bancorp
USB
$99.2B
$37M 3.26%
853,573
-74,500
-8% -$3.26M
EMC
11
DELISTED
EMC CORPORATION
EMC
$36.7M 3.23%
1,391,022
-77,100
-5% -$2.06M
CVS icon
12
CVS Health
CVS
$141B
$36M 3.17%
342,986
-45,350
-12% -$4.63M
C icon
13
Citigroup
C
$223B
$35.9M 3.17%
650,600
+36,500
+6% +$1.99M
BA icon
14
Boeing
BA
$161B
$35.3M 3.11%
254,650
+22,903
+10% +$3.34M
MSFT icon
15
Microsoft
MSFT
$2.95T
$33.9M 2.98%
767,027
-109,400
-12% -$4.99M
KR icon
16
Kroger
KR
$35.4B
$32.2M 2.84%
888,080
-149,720
-14% -$5.44M
T icon
17
AT&T
T
$155B
$31.6M 2.79%
1,178,659
-275,260
-19% -$7.11M
PFE icon
18
Pfizer
PFE
$142B
$29.4M 2.59%
924,584
-92,962
-9% -$3.03M
VLO icon
19
Valero Energy
VLO
$93.5B
$25.5M 2.24%
406,658
-27,900
-6% -$1.65M
HES
20
DELISTED
Hess
HES
$25.1M 2.21%
375,000
+55,364
+17% +$3.93M
CSCO icon
21
Cisco
CSCO
$442B
$25M 2.21%
911,584
-21,800
-2% -$625K
IP icon
22
International Paper
IP
$19.2B
$24.2M 2.13%
536,001
+35,059
+7% +$1.74M
MDT icon
23
Medtronic
MDT
$105B
$24M 2.12%
324,500
+193,700
+148% +$14.8M
DAL icon
24
Delta Air Lines
DAL
$55.7B
$21.7M 1.91%
527,285
-42,700
-7% -$1.87M
OXY icon
25
Occidental Petroleum
OXY
$56.2B
$18.5M 1.63%
238,155
+11,325
+5% +$885K

Similar funds

Colrain Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Colrain Capital held 98 positions worth $1.14B, down 5.4% from $1.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Colrain Capital withdrew a net $67M in Q2 2015, closing 9 positions and reducing 57 holdings. Its most notable exit was Lumen, an estimated $2.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Technology.

Against the trend, Colrain Capital opened a new position in Coca-Cola worth $1.73M.

  • Colrain Capital's largest Q2 2015 buy was Coca-Cola: 44,000 shares worth $1.73M.
  • Colrain Capital added most to Medtronic in Q2 2015, an estimated $14.8M increase.
  • Colrain Capital's biggest Q2 2015 reduction was Viatris, cutting an estimated $10.3M.
  • Colrain Capital fully exited Lumen in Q2 2015, selling an estimated $2.68M.
  • Colrain Capital's ten largest holdings make up 38% of its $1.14B portfolio in Q2 2015.
  • Colrain Capital opened 9 new positions and closed 9 in Q2 2015.
  • Colrain Capital's portfolio value fell 5.4% quarter-over-quarter to $1.14B.

Based on Colrain Capital's 13F filing for Q2 2015, filed 11 Aug 2015.